| Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data … P Brito-Zerón, N Acar-Denizli, M Zeher, A Rasmussen, R Seror, ... Annals of the rheumatic diseases 76 (6), 1042-1050, 2017 | 184 | 2017 |
| How immunological profile drives clinical phenotype of primary Sjogren's syndrome at diagnosis: analysis of 10,500 patients (Sjogren Big Data Project) P Brito-Zerón, N Acar-Denizli, WF Ng, M Zeher, A Rasmussen, T Mandl, ... Clinical and experimental rheumatology 36 (3), S102-S112, 2018 | 173 | 2018 |
| Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis. L Soós, Z Szekanecz, Z Szabó, A Fekete, M Zeher, IF Horváth, K Dankó, ... The Journal of rheumatology 34 (8), 1658-1663, 2007 | 146 | 2007 |
| Altered T-cell and regulatory cell repertoire in patients with diffuse cutaneous systemic sclerosis G Papp, IF Horvath, S Barath, E Gyimesi, S Sipka, P Szodoray, M Zeher Scandinavian journal of rheumatology 40 (3), 205-210, 2011 | 104 | 2011 |
| Variants of the IL23R gene are associated with ankylosing spondylitis but not with Sjögren syndrome in Hungarian population samples E Safrany, B Pazar, V Csöngei, L Jaromi, N Polgar, C Sipeky, IF Horváth, ... Scandinavian journal of immunology 70 (1), 68-74, 2009 | 94 | 2009 |
| Cells with regulatory function of the innate and adaptive immune system in primary Sjögren’s syndrome P Szodoray, G Papp, IF Horvath, S Barath, S Sipka, B Nakken, M Zeher Clinical & Experimental Immunology 157 (3), 343-349, 2009 | 93 | 2009 |
| Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients S Retamozo, N Acar-Denizli, A Rasmussen, IF Horváth, C Baldini, R Priori, ... Clinical and experimental rheumatology 37 (3 (S118)), 97-106, 2019 | 80 | 2019 |
| Anti-cyclic citrullinated peptide antibody isotypes in rheumatoid arthritis: association with disease duration, rheumatoid factor production and the presence of shared epitope G Lakos, L Soós, A Fekete, Z Szabo, M Zeher, IF Horváth, K Dankó, ... Clinical and experimental rheumatology 26 (2), 253, 2008 | 77 | 2008 |
| Epidemiological profile and north–south gradient driving baseline systemic involvement of primary Sjögren’s syndrome P Brito-Zerón, N Acar-Denizli, WF Ng, IF Horvath, A Rasmussen, R Seror, ... Rheumatology 59 (9), 2350-2359, 2020 | 71 | 2020 |
| Autoimmune thyroid diseases in a large group of Hungarian patients with primary Sjögren's syndrome M Zeher, IF Horvath, A Szanto, P Szodoray Thyroid 19 (1), 39-45, 2009 | 70 | 2009 |
| Clinical course, prognosis, and cause of death in primary Sjögren’s syndrome IF Horvath, A Szanto, G Papp, M Zeher Journal of immunology research 2014, 2014 | 61 | 2014 |
| The immunoregulatory role of vitamins A, D and E in patients with primary Sjögren’s syndrome P Szodoray, IF Horvath, G Papp, S Barath, E Gyimesi, L Csathy, ... Rheumatology 49 (2), 211-217, 2010 | 61 | 2010 |
| Immunomodulatory effects of extracorporeal photochemotherapy in systemic sclerosis G Papp, IF Horvath, S Barath, E Gyimesi, J Vegh, P Szodoray, M Zeher Clinical immunology 142 (2), 150-159, 2012 | 58 | 2012 |
| Immunological alterations in newly diagnosed primary Sjögren's syndrome characterized by skewed peripheral T‐cell subsets and inflammatory cytokines P Szodoray, I Gal, S Barath, M Aleksza, IF Horvath, P Gergely Jr, ... Scandinavian journal of rheumatology 37 (3), 205-212, 2008 | 55 | 2008 |
| Primary Sjögren’s syndrome in men: clinical and immunological characteristic based on a large cohort of Hungarian patients IF Horvath, P Szodoray, M Zeher Clinical rheumatology 27, 1479-1483, 2008 | 43 | 2008 |
| Superior performance of the CCP3. 1 test compared to CCP2 and MCV in the rheumatoid factor-negative RA population Z Szekanecz, Z Szabó, M Zeher, L Soós, K Dankó, I Horváth, G Lakos Immunologic research 56, 439-443, 2013 | 42 | 2013 |
| Thu0628 immune-related adverse events induced by cancer immunotherapies. Big data analysis of 13,051 cases (Immunocancer international registry) M Ramos-Casals, O Lambotte, M Kostine, L Calabrese, ... Annals of the Rheumatic Diseases 78 (Suppl 2), 607-608, 2019 | 24 | 2019 |
| Influence of the age at diagnosis in the disease expression of primary Sjögren syndrome. Analysis of 12,753 patients from the Sjögren Big Data Consortium S Retamozo, N Acar-Denizli, IF Horváth, WF Ng, A Rasmussen, X Dong, ... Clinical and experimental rheumatology 39 (6), S166-S174, 2021 | 20 | 2021 |
| Autoantibodies to alfa-fodrin in patients with Hashimoto thyroiditis and Sjögren’s syndrome: possible markers for a common secretory disorder A Szanto, I Csipo, I Horvath, E Biro, P Szodoray, M Zeher Rheumatology international 28, 1169-1172, 2008 | 20 | 2008 |
| Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies G Hernández-Molina, B Kostov, P Brito-Zerón, A Vissink, T Mandl, ... Rheumatology 62 (1), 243-255, 2023 | 19 | 2023 |
Zeher MargitDebreceni Egyetem Orvos és Egészségtudományi Centrum Belgyógyászati Intézet Klinikai ImmunológiaVerified email at iiibel.dote.hu
